• Users Online: 120
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2018  |  Volume : 9  |  Issue : 1  |  Page : 94

Death outcome with successful treatment of tuberculosis patients

Department of Public Health Sciences, The Graduate School, University of Muhammadiyah Prof. Dr. Hamka (UHAMKA), South Jakarta, Indonesia

Date of Submission14-Jan-2018
Date of Acceptance12-Feb-2018
Date of Web Publication12-Oct-2018

Correspondence Address:
Al Asyary
Jl. Warung Buncit Raya No. 17, Pancoran, Jakarta Selatan 12790
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijpvm.IJPVM_30_18

Rights and Permissions

How to cite this article:
Al Asyary. Death outcome with successful treatment of tuberculosis patients. Int J Prev Med 2018;9:94

How to cite this URL:
Al Asyary. Death outcome with successful treatment of tuberculosis patients. Int J Prev Med [serial online] 2018 [cited 2021 Sep 20];9:94. Available from: https://www.ijpvmjournal.net/text.asp?2018/9/1/94/243212

Dear Editor,

I read the previous publication on death outcome after successful treatment of smear-positive tuberculosis (TB).[1] Moosazadeh et al. presented a cohort study in Iranian Registry Setting which concluded that the “Positive smear pulmonary TB even after successful treatment has an adverse effect on the patients' survival and leads to a decrease in their survival rate in the long run.”[1] I agree with the cohort methodology and survivals' data analysis of such an evidence. However, I am concerned about stratification[2] to analyze separately the effect of either diabetes, renal disease, cancer, previous TB treatment, or age group. I am wondering how the adjustable effects' result after these variables are stratified with death status in different population settings.

Furthermore, strategy of directly observed treatments therapy is an established approach to mitigate TB burden, particularly in developing countries.[3] The study of Moosazadeh et al. may reflect on this strategy in a way. A side effects' study is essential to confirm for further.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest

  References Top

Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N. Survival and predictors of death after successful treatment among smear positive tuberculosis: A cohort study. Int J Prev Med 2014;5:1005-12.  Back to cited text no. 1
Kleinbaum DG, Klein M. Survival Analysis. New York: Springer; 2010.  Back to cited text no. 2
World Health Organization, STOP TB Initiative (World Health Organization). Treatment of Tuberculosis: Guidelines. Geneva, Switzerland: World Health Organization; 2010.  Back to cited text no. 3


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded130    
    Comments [Add]    

Recommend this journal